N-(3-((4-ethylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)-3-(1H-indazol-6-yl)-4-methyl benzamide

ID: ALA4521671

PubChem CID: 155542710

Max Phase: Preclinical

Molecular Formula: C29H30F3N5O

Molecular Weight: 521.59

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5cn[nH]c5c4)c3)cc(C(F)(F)F)c2)CC1

Standard InChI:  InChI=1S/C29H30F3N5O/c1-3-36-8-10-37(11-9-36)18-20-12-24(29(30,31)32)16-25(13-20)34-28(38)22-5-4-19(2)26(14-22)21-6-7-23-17-33-35-27(23)15-21/h4-7,12-17H,3,8-11,18H2,1-2H3,(H,33,35)(H,34,38)

Standard InChI Key:  ZXLPISITSIDONA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    3.9206   -8.7937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6303   -8.3842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6274   -7.5616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9188   -7.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2125   -8.3847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2092   -7.5637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4273   -7.3131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9473   -7.9793    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4327   -8.6415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3306   -7.1516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0401   -7.5592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7458   -7.1487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7431   -6.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0289   -5.9249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3262   -6.3378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6158   -5.9338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4548   -7.5549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4575   -8.3721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1612   -7.1440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8702   -7.5503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8693   -8.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5776   -8.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2849   -8.3622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2796   -7.5408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5708   -7.1383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9870   -7.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6284   -6.7473    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.7873   -7.4215    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.1175   -6.2795    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.5798   -9.5904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2887   -9.9970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2850  -10.8142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9898  -11.2207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6988  -10.8136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6985   -9.9955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9892   -9.5845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4061  -11.2229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1142  -10.8150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  3 10  1  0
 15 16  1  0
 12 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 24 26  1  0
 22 30  1  0
 30 31  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4521671

    ---

Associated Targets(Human)

FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DDR2 Tchem Discoidin domain-containing receptor 2 (2199 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.59Molecular Weight (Monoisotopic): 521.2402AlogP: 5.95#Rotatable Bonds: 6
Polar Surface Area: 64.26Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.93CX Basic pKa: 7.92CX LogP: 5.57CX LogD: 4.94
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.77

References

1. Wang Q, Dai Y, Ji Y, Shi H, Guo Z, Chen D, Chen Y, Peng X, Gao Y, Wang X, Chen L, Jiang Y, Geng M, Shen J, Ai J, Xiong B..  (2019)  Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma.,  163  [PMID:30572178] [10.1016/j.ejmech.2018.12.015]

Source